We focused on LGALS3BP, which was shown to be particularly up-regulated in MTX-resistant cells and had been proven to be an oncogene in several cancers, while its function in the regulation of MTX resistance in GTNs still remains poorly understood. This evidence concerns the gene LGALS3BP and cancer.